Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Diabetes: The Chocolate Touch Study.
Tanja BöhmeThomas ZellerMehdi H ShishehborMartin WernerMarianne BrodmannHelen PariseAndrew HoldenMichael LichtenbergSahil A ParikhVikram S KashyapCody PietrasDaniela TirziuUlrich BeschornerPrakash KrishnanKhusrow A NiaziAndreas U WaliAlexandra J LanksyPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2023)
This substudy of the Chocolate Touch Study demonstrated similar safety and efficacy for treatment of femoropopliteal disease of the Chocolate Touch DCB compared with the Lutonix DCB regardless of diabetes (DM) status at 12 months. Endovascular therapy has become the therapy of choice for the treatment of most symptomatic femoropopliteal lesions regardless of DM status. These results give clinicians another option when treating femoropopliteal disease in this high-risk patient population.